CD8A and neoplasm: This maneuver can result in efficient local priming of tumor‐specific CD8+ T cells that are to be de‐repressed by checkpoint inhibitors in triple regimens for cancer immunotherapy, in an attempt to attain synergistic effects in the clinic.